Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys

Growth Hormone and IGF Research

Volumn 10, Issue 6, 2000, Pages 324-331

  Zachrisson, I ^a   Brismar, K ^a   Carlsson Skwirut, C ^a   Dahlquist, G ^b   Wallensteen, M ^a   Bang, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes mellitus; IGF I; IGFBP 1; IGFBP 3; Insulin resistance; Proteolysis; Puberty

Indexed keywords

GROWTH HORMONE; INSULIN; PROTEINASE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; CHILD GROWTH; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GROWTH HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PUBERTY; SEXUAL MATURATION;

EID: 0034492174     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.2000.0170     Document Type: Article

References (30)

1. Impaired insulin action in puberty
2. Puberty decreases insulin sensitivity
3. Diabetes in puberty
4. Determinants of blood glucose variability in adolescents with insulin-dependent diabetes mellitus
5. Glucose-induced insulin response and insulin sensitivity is not related to HLA-type but to age in young siblings of type 1 (insulin dependent) diabetic patients
6. Insulin sensitivity and glucose-induced insulin response changes during adolescence
7. Changes in serum insulin concentration during puberty and their relationship to growth hormone
8. Insulin-like growth factor-binding protein-1 modulates blood glucose levels
9. Role of IGF-binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM
10. Free insulin-like growth factors (IGF-I and IGF-II) in human serum
11. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum
12. Insulin-like growth factor binding proteins as glucoregulators
13. Serum proteolysis of IGFBP-3
14. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma
15. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein- 1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes
16. Clinical applications of IGFBP-1 and its regulation
17. Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline
18. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex
19. Postoperative induction of insulin-like growth factor binding protein-3 proteolytic activity: Relation to insulin and insulin sensitivity
20. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults
21. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus
22. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type I diabetes: Evidence for in vivo biological activity
23. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion
24. Insulin-like growth factor binding protein-1 as glucose regulator in adolescent boys with type 1 diabetes
25. A simple assay for proteolysis of IGFBP-3
26. Crossreaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid
27. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determination in acid ethanol extracts by use of truncated IGF-1 as radioligand
28. Estimation of blood-glucose variability in patients with insulin-dependent diabetes mellitus
29. The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus
30. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity